• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of Aberration for molecules of p53-depandent Apoptosis in hepatocellular carcinoma and Gastrointestinal Cancer

Research Project

Project/Area Number 14570466
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

NISHIDA Naoshi  Kyoto University, Graduate School of Medicine, instructor, 医学研究科, 助手 (60281755)

Co-Investigator(Kenkyū-buntansha) FUKUDA Yoshihiro  Kyoto University, Faculty of Medicine, professor, 医学部, 教授 (50127130)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2002: ¥2,100,000 (Direct Cost: ¥2,100,000)
KeywordsHepatocellular carcinoma / P53 pathway / p14 gene / chromosomal instability / deletion / methylation / carcinogenesis / 突然変異 / 発癌
Research Abstract

We investigated mutation, deletion and aberrant methylation of the p14^<ARF> gene in 44 human hepatocellular carcinoma by using PCR-SSCP, direct sequencing, multiplex-PCR and methylation specific-PCR. In addition, we studied expression of p14^<ARF> with Real-Time PCR, expression of p53 with immunohistochemistry and examined chromosomalinstability by using semiquantitative microsatellite analysis. We found mutation of p14^<ARF> in two HCCs and deletion in one HCC, however aberrant promoter methylation was not detected in any cases.
Examination of Real-Time PCR revealed that overexpression of p14^<ARF> was detected in all but one HCC with p14^<ARF> deletion, suggesting that aberration of transcriptional regulation was not take place during hepatocarcinogenesis. In addition, p14^<ARF> overexpression was associated with poorly differentiated phenotype. All three HCCs with p14^<ARF> alteration were well-differentiated. On the other hand, twelve HCCs showed aberration of p53 with immunohistochemistry and only one was well-differentiated HCC among them. These data indicate that p53 pathway play an important role in a subset of HCC formation.
Chromosomal alteration was observed in all HCCs examined including well-differentiated HCC and p53 pathway aberration may accelerate chromosomal instability of HCC cell expanding altered chromosomal region and contribute to it's progression.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Ito, T., Nishida, N.et al.: "Alteration of the p14ARF gene and p53 status in human hepatocellular carcinoma."J.Gstroenterology. in press. (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishida, N. et al.: "Chromosomal instability and human hepatocarcinogenesis."Histol. Histopathol.. 18. 897-909 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishimura, T., Nishida, N.et al.: "Comprehensive Allelotyping of Well-Differentiated Human Hepatocellular Carcinoma with Semiquantitative Determination of Chromosomal Gain or Loss."Genes, Chromosomes and Cancer. 35. 329-339 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishida, N. et al.: "Prognostic Impact of Multiple Allelic losses for metastatic recurrence in hepatocellular carcinoma after Curative Resection."Oncology. 62. 141-148 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Azechi, H., Nishida, N.et al.: "Disruption of the RB pathway in the majority of human hepatocellular carcinomas."Oncology. 60. 346-354 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 中村典明, 西田直生志, 有井滋樹: "遺伝子医学別冊"メディカル・ドュ社. 6 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Azechi H: "Disruption of the RB pathway in the majority of human hepatocellular carcinomas."Oncology. 60. 346-354 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishida N: "Prognostic Impact of Multiple Allelic losses for metastatic recurrence in hepatocellular carcinoma after Curative Resection."Oncology. 62. 141-148 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishimura T: "Comprehensive Allelotyping of Well-Differentiated Human Hepatocellular Carcinoma with Semiquantitative Determination of Chromosomal Gain or Loss."Genes, Chromosomes and Cancer. 35. 329-339 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishida N: "Chromosomal instability and human hepatocarcinogenesis."Histol.Histopathol.. 18. 897-909 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito T: "Alteration of the p14^<ARF> gene and p53 status in human hepatocellular carcinoma."J.Gastroenterology. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito, T., Nishida, N.et al.: "Alteration of the p14ARF gene and p53 status in human hepatocellular carcinoma"J.Gstroenterology. in press. (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nishida, N. et al.: "Chromosomal instability and human hepatocarcinogenesis"Histol.Histopathol.. 18. 897-909 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nishimura, T., Nishida, N.et al.: "Comprehensive Allelotyping of Well-Differentiated Human Hepatocellular Carcinoma with Semiquantitative Determination of Chromosomal Gain or Loss"Genes, Chromosomes and Cancer. 35. 329-339 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nishida, N. et al.: "Prognostic Impact of Multiple Allelic losses for metastatic recurrence in hepatocellular carcinoma after Curative Resection"Oncology. 62. 141-148 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] 中村典明, 西田直生志, 有井滋樹: "遺伝子医学別冊"メディカル・ドュ社. 6 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nishida, N. et al.: "Chromosomal inhibility and human hepatocarcinogenesis"Histology and Histopathology. (in press). 2003

    • Related Report
      2002 Annual Research Report
  • [Publications] Nishimura, T., Nishida, N.et al.: "Comprehensive Allelotyping of Well-Differentiated Human Hepatocellular Carcinoma with Semiquantitative Determination of Chromosomal Gain or Loss"Genes, Chromosomes & Cancer. 35. 329-339 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tanaka, A., Nishida, N.et al.: "Treatment of ruptured hepatocellular carcinoma"Int. J. Clin. Oncol.. 6. 291-295 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] "Disruption of the RB pathway in the majority of human hepatocellular carcinomas"

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi